Cargando…
Dendrimer-based posaconazole nanoplatform for antifungal therapy
We examined formulating a new antifungal agent, posaconazole (POS) and its derivatives, with different molecular vehicles. Several combinations of drug and carrier molecules were synthesized, and their antifungal activities were evaluated against Aspergillus fumigatus. Posaconazole and four of its d...
Autores principales: | Tang, Shengzhuang, Chen, Jesse, Cannon, Jayme, Cao, Zhengyi, Baker, James R., Wang, Su He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510609/ https://www.ncbi.nlm.nih.gov/pubmed/34617850 http://dx.doi.org/10.1080/10717544.2021.1986605 |
Ejemplares similares
-
Delicate Hybrid Laponite–Cyclic Poly(ethylene glycol) Nanoparticles as a Potential Drug Delivery System
por: Tang, Shengzhuang, et al.
Publicado: (2023) -
Effective Treatment of Skin Wounds Co-Infected with Multidrug-Resistant Bacteria with a Novel Nanoemulsion
por: Chen, Jesse, et al.
Publicado: (2022) -
A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy
por: Hao, Yingchao, et al.
Publicado: (2022) -
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015) -
Effectiveness of Posaconazole in Recalcitrant Fungal Keratitis Resistant to Conventional Antifungal Drugs
por: Altun, A., et al.
Publicado: (2014)